Letters Patient information on drugs

Author’s reply to Mintzes

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4904 (Published 02 August 2011) Cite this as: BMJ 2011;343:d4904
  1. Joanne M Shaw, chairman1
  1. 1Datapharm Communications Limited, Leatherhead, Surrey, UK
  1. joanne.shaw{at}healthstrategy.org

I support Mintzes’ concern about protecting the public from covert drugs promotion.1 2 But her fear and dislike of the drug industry has blinded her to the realisation that the control of information by well intentioned health professionals is unhelpful to patients. …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe